2023
The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China
Chang D, Lin M, Song N, Zhu Z, Gao J, Li S, Liu H, Liu D, Zhang Y, Sun W, Zhou X, Yang B, Li Y, Wang L, Xiao Z, Li K, Xing L, Xie L, Sharma L. The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China. Virology Journal 2023, 20: 189. PMID: 37620959, PMCID: PMC10463403, DOI: 10.1186/s12985-023-02115-x.Peer-Reviewed Original ResearchConceptsInfluenza BAverage ageCOVID-19Influenza-like illnessNumber of patientsMajor respiratory pathogenCOVID-19 testCOVID-19-related restrictionsCell death markersClinical characteristicsFever clinicYounger patientsAppropriate vaccinationPatient characteristicsSubstantial morbidityRespiratory virusesSeasonal virusesLaboratory findingsPositivity rateInfluenza ARespiratory pathogensPreventive strategiesSecondary infectionSevere casesFlu season
2020
The kinetics of humoral response and its relationship with the disease severity in COVID-19
Ren L, Zhang L, Chang D, Wang J, Hu Y, Chen H, Guo L, Wu C, Wang C, Wang Y, Wang Y, Wang G, Yang S, Dela Cruz CS, Sharma L, Wang L, Zhang D, Wang J. The kinetics of humoral response and its relationship with the disease severity in COVID-19. Communications Biology 2020, 3: 780. PMID: 33311543, PMCID: PMC7733479, DOI: 10.1038/s42003-020-01526-8.Peer-Reviewed Original ResearchConceptsHumoral responseDisease severityReceptor-binding domainAntibody titersSpike proteinSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2COVID-19Respiratory syndrome coronavirus 2Titers of NAbsGeometric mean titersCOVID-19 patientsSyndrome coronavirus 2Coronavirus disease 2019Disease courseMean titersCoronavirus 2Antibody responseIgG antibodiesRisk factorsIg levelsImmunoglobulin ADisease 2019Severe casesModerate infections
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply